Recombinant bovine basic fibroblast growth factor for external use (Zhuhai EssexBio)

重组牛碱性成纤维细胞生长因子外用溶液(珠海亿胜生物制药)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant bovine basic fibroblast growth factor for external use (Zhuhai EssexBio)
Drug Alias Name贝复济
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors modulators
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsBurnsSkin Ulcer
Global Approved IndicationsBurnsSkin Ulcer
Approved Indications in ChinaBurnsSkin Ulcer
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBurnsSkin Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A